BIS icon

ProShares UltraShort NASDAQ Biotechnology

8 hedge funds and large institutions have $3.51M invested in ProShares UltraShort NASDAQ Biotechnology in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
2
Reduced
2
Closed
3
Calls
$560K
Puts
$211K
Net Calls
+$349K
Net Calls Change
+$257K
Name Holding Trade Value Shares
Change
Shares
Change %
WP
1
WealthSource Partners
California
$1.44M +$1.44M +21,500 New
Citadel Advisors
2
Citadel Advisors
Florida
$836K -$68.8K -1,028 -8%
TRCT
3
Tower Research Capital (TRC)
New York
$642K +$332K +4,976 +107%
VF
4
Virtu Financial
New York
$319K +$319K +4,767 New
HF
5
HRT Financial
New York
$228K +$228K +3,420 New
UBS Group
6
UBS Group
Switzerland
$38K -$18.7K -278 -33%
Citigroup
7
Citigroup
New York
$6K
Morgan Stanley
8
Morgan Stanley
New York
$6K +$5.81K +93 +3,100%
HVC
9
Healthcare Value Capital
New Jersey
-$3.45M -37,500 Closed
Jane Street
10
Jane Street
New York
-$979K -10,597 Closed
GCM
11
Gunderson Capital Management
South Carolina
-$918K -9,935 Closed